What We're Reading: Page 127
Industry reads hand-picked by our editors
Jan 28, 2022
Jan 27, 2022
-
The Boston Globe
Massachusetts biopharma firms raised a record $13.7 billion in venture capital last year
-
Financial Times
GSK kicks off trials of pioneering 'bioelectronic' disease treatment
-
STAT
Early research suggests cancer drug could help flush HIV from its hiding spots
-
Fortune
How Novavax's COVID vaccine gained a cult-like following before US approval
Jan 26, 2022
Jan 25, 2022
-
Bloomberg Law
Califf on Path to Win FDA Chief Role Despite Expected 'No' Votes
-
The Washington Post
FDA ends for now use of two monoclonal antibodies, spurring a halt in federal shipments of the Covid-19 treatments
-
Axios
Mark Cuban launches digital pharmacy promising steep discounts on generic drugs
-
The Atlantic
How a Rare Brain Mutation Spread Across America
Jan 24, 2022
-
Dallas News
Mark Cuban’s online pharmacy is now open with low-cost prescription drugs
-
STAT
Did veteran drug developer Hal Barron accomplish his mission at GSK?
-
Chemical & Engineering News
Many of our proteins remain hidden in the dark proteome
-
The New York Times
How Omicron Is Different Than Delta
Jan 21, 2022
-
Reuters
Alzheimer's patient groups protest U.S. Medicare coverage proposal limiting use of new drugs
-
The New York Times
Deborah Nickerson, Pioneering Genome Researcher, Dies at 67
-
The Wall Street Journal
Unilever Walks Away From Glaxo Consumer-Healthcare Deal
-
STAT
Study casts doubt on how combination cancer therapies work in tandem
Jan 20, 2022
-
CNBC
Fauci says FDA could authorize Pfizer's Covid vaccine for kids under 5 in the next month
-
Bloomberg Law
Merck's $1.4 Billion Insurance Win Splits Cyber From 'Act of War'
-
Bloomberg
One Shot to Protect Against All Covid-19 Variants
-
MIT Technology Review
Going bald? Lab-grown hair cells could be on the way
Previous
